Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:479
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 62 条
[41]   Overdiagnosis and overtreatment of breast cancer - Overdiagnosis in randomised controlled trials of breast cancer screening [J].
Moss, S .
BREAST CANCER RESEARCH, 2005, 7 (05) :230-234
[42]   Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial [J].
Moss, Sue M. ;
Cuckle, Howard ;
Evans, Andy ;
Johns, Louise ;
Waller, Michael ;
Bobrow, Lynda .
LANCET, 2006, 368 (9552) :2053-2060
[43]  
*NAT CANC I, 2002, NCI STAT MAMM SCREEN
[44]  
*NAT COMPR CANC NE, NCCN CLIN PRACT GUID
[45]   Protection of mammography screening against death from breast cancer in women aged 40-64 years [J].
Norman, Sandra A. ;
Localio, A. Russell ;
Anita, L. Weber ;
Coates, Ralph J. ;
Zhou, Lan ;
Bernstein, Leslie ;
Malone, Kathleen E. ;
Marchbanks, Polly A. ;
Weiss, Linda K. ;
Lee, Nancy C. ;
Nadel, Marion R. .
CANCER CAUSES & CONTROL, 2007, 18 (09) :909-918
[46]   Long-term effects of mammography screening:: updated overview of the Swedish randomised trials [J].
Nyström, L ;
Andersson, I ;
Bjurstam, N ;
Frisell, J ;
Nordenskjöld, B ;
Rutqvist, LE .
LANCET, 2002, 359 (9310) :909-919
[47]  
Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012
[48]   The decrease in breast-cancer incidence in 2003 in the United States. [J].
Ravdin, Peter M. ;
Cronin, Kathleen A. ;
Howlader, Nadia ;
Berg, Christine D. ;
Chlebowski, Rowan T. ;
Feuer, Eric J. ;
Edwards, Brenda K. ;
Berry, Donald A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (16) :1670-1674
[49]  
Rosenberg Marjorie A, 2006, J Natl Cancer Inst Monogr, P15, DOI 10.1093/jncimonographs/lgj004
[50]   Performance benchmarks for screening mammography [J].
Rosenberg, Robert D. ;
Yankaskas, Bonnie C. ;
Abraham, Linn A. ;
Sickles, Edward A. ;
Lehman, Constance D. ;
Geller, Berta M. ;
Carney, Patricia A. ;
Kerlikowske, Karla ;
Buist, Diana S. M. ;
Weaver, Donald L. ;
Barlow, William E. ;
Ballard-Barbash, Rachel .
RADIOLOGY, 2006, 241 (01) :55-66